Firebrick Pharma Limited (ASX:FRE)

Firebrick Pharma Revenue

Firebrick Pharma had revenue of 92.26K AUD in the half year ending December 31, 2025, a decrease of -94.92%. This brings the company's revenue in the last twelve months to 410.70K, down -63.70% year-over-year. In the fiscal year ending June 30, 2025, Firebrick Pharma had annual revenue of 515.51K, down -81.26%.

• Revenue (ttm): 410.70K
• Revenue Growth: -63.70%
• P/S Ratio: 18.06
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 7.42M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	515.51K	-2.23M	-81.26%
Jun 30, 2024	2.75M	2.73M	12,096.48%
Jun 30, 2023	22.55K	-1.06M	-97.92%
Jun 30, 2022	1.08M	661.35K	156.72%
Jun 30, 2021	422.00K	-86.98K	-17.09%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 6, 2026

Data Sources Report a data error